News

Lisata Therapeutics CEO to Share Insights at Upcoming Summit

Lisata Therapeutics CEO to Share Insights at Upcoming Summit

Lisata Therapeutics to Showcase Corporate Insights at Investor Summit

Lisata Therapeutics, Inc. (Nasdaq: LSTA), a prominent clinical-stage pharmaceutical company, is gearing up to present at an important upcoming investor event. The company's mission revolves around pioneering innovative therapies designed for the treatment of advanced solid tumors and other serious health conditions.

David J. Mazzo, PhD, the President and CEO of Lisata, will take the stage at the Sequire Investor Summit on January 22 to provide a detailed corporate overview. The summit, held in San Juan, offers a key opportunity for discussions surrounding the latest advancements and future directions of the company.

Overview of the Sequire Investor Summit

The Sequire Investor Summit is poised to attract numerous industry leaders and investors eager to learn about breakthrough innovations in the pharmaceutical sector. Dr. Mazzo's presentation will take place at 10:00 a.m. Atlantic Standard Time, where he is expected to highlight Lisata's strategic focus, recent developments, and ongoing research efforts.

Importance of Engagement in Current Markets

Events like the Sequire Investor Summit provide invaluable engagement prospects, allowing companies to connect directly with potential investors and share their vision for the future. For Lisata, this is more than just a presentation; it is an opportunity to showcase its ground-breaking research milestones and foster relationships within the investment community.

About Lisata Therapeutics

Lisata Therapeutics stands out in the pharmacy industry by being dedicated to discovering and developing transformative therapies. Their investigational product candidate, certepetide, utilizes a unique mechanism that enables targeted delivery of chemotherapy drugs to solid tumors, potentially improving treatment outcomes for patients.

Strategic Partnerships and Innovations

The company has already established significant research and commercial collaborations, particularly surrounding its CendR Platform technology. These partnerships not only enhance Lisata's capabilities but also support the advancement of their innovative therapies.

Lisata is committed to maintaining a pathway of growth and evolution in its clinical trials and expects to reveal several critical milestones within the next year and a half. These advancements will be essential for ensuring that the company remains at the forefront of cancer treatment innovation.

Future Projections and Expectations

The leadership team at Lisata Therapeutics anticipates that their current funding will effectively support operations through early 2026, paving the way for further clinical development and the release of crucial trial data. This commitment underscores the team's dedication to pushing the boundaries of science to improve patient care.

Contact Information for Investors and Media

For investors wanting more information about Lisata's future endeavors, contact John Menditto, Vice President of Investor Relations and Corporate Communications, at 908-842-0084 or via email at jmenditto@lisata.com.

Media inquiries can be directed to Elizabeth Coleman at ICR Healthcare by calling 203-682-4783 or emailing elizabeth.coleman@icrhealthcare.com.

Frequently Asked Questions

What is Lisata Therapeutics known for?

Lisata Therapeutics is recognized for developing innovative therapies targeting advanced solid tumors and serious diseases.

Who will present at the Sequire Investor Summit?

Dr. David J. Mazzo, the President and CEO of Lisata Therapeutics, will present at the summit.

When is the Sequire Investor Summit taking place?

The Sequire Investor Summit will be held from January 21-23.

What is the significance of certepetide?

Certepetide is an investigational drug designed for more effective targeting and penetration of solid tumors during treatment.

How can I contact Lisata Therapeutics for more information?

Investors can reach out to John Menditto at 908-842-0084 or via email, while media inquiries can be directed to Elizabeth Coleman at ICR Healthcare.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Zensar Sees Solid Revenue Growth in Q2FY27

Updated Category News Views 0

Zensar's Q2 Performance: Growth Amid Shifting Sands Is Zensar Technologies quietly carving a spot for itself in the cutthroat tech marketplace, or are we just seeing a temporary glimmer during a complex market scenario? With a constant currency growth rate of 4.1% in Q2FY27, Zensar sure seems to have gotten something right. But does this mean they’ve got the long-term...

Continue Reading
ElektraFi Challenges Starlink: Fixed Wireless Gains Edge

Updated Category News Views 0

Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 160

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading
Investcorp's Strong 2026: A Deep Dive into Key Moves

Updated Category News Views 159

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Continue Reading
Ebix and intentyx Tackle AI Security in Regulated Fields

Updated Category News Views 6

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

Continue Reading
Celebree's Gratitude Push: Kindness Turns into Action

Updated Category News Views 0

Expressing Gratitude: More than Just Words Gratitude: it's one of those feel-good concepts that everyone nods to, but let's face it—most folks don't really go beyond the occasional 'thanks.' That's where the Generation Gratitude Project by Celebree School steps in. The idea's not just about saying thanks, but about making it a real, action-oriented habit. This campaign,...

Continue Reading
Tactical Comm Market: $19.39B by 2031 Amid 8.1% CAGR

Updated Category News Views 49

Riding the Tactical Communication Wave Alright, here’s something to chew on over your morning coffee. The tactical communication market is projected to balloon from USD 13.14 billion in 2026 to a whopping USD 19.39 billion by 2031. That’s an 8.1% CAGR if you’re keeping track—no small peanuts. So what's driving this surge? It’s all about security, modernization,...

Continue Reading
Lazard Closes Deal with Campbell, Launches Lazard CL

Updated Category News Views 59

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

Continue Reading
XPENG Gears Up for Q3 2026 Results Amid AI Advancements

Updated Category News Views 70

XPENG's Upcoming Financial Disclosure XPENG Inc., a name that rings bells in the smart mobility world, is setting the stage for its third quarter 2026 financial results on November 16. Someone with a sharp enough gut could probably see it a mile away—these numbers might just be the ticket for a ride amid XPENG's high wire AI advancements. But let's not kid ourselves;...

Continue Reading
Pak Mail Jonesboro Dominates at Annex Brands Convention

Updated Category News Views 0

Small Town, Big Impact at the Annex Brands Shindig From little Jonesboro, Arkansas, comes a thunderous clap for the Kincades, who bagged a bunch of trophies and accolades at the big 2026 Annex Brands National Convention. Tim and Rhonda Kincade, the ones running Pak Mail Jonesboro, didn't just show up—they brought home the bacon with honors piled as high as the Ozarks....

Continue Reading

Top 5 Most Recently Viewed Articles

Farmers Insurance Exchange Investigated for Data Breach Issues

Updated Category News Views 193

Investigation of Farmers Insurance Exchange Regarding Data Breach Bragar Eagel & Squire, P.C., a prominent litigation firm, is currently looking into the recent data breach incident involving Farmers Insurance Exchange. The firm emphasizes that anyone affected should not hesitate to reach out for legal assistance. Details Surrounding the Breach On a significant date in...

Continue Reading
Rapidan Energy Group Welcomes New Experts to Its Leadership Team

Updated Category News Views 224

Rapidan Energy Group Strengthens Team with New Additions Rapidan Energy Group is excited to share the news of its newest team members, Richard W. Powers, Bryson L. Rexwinkle, and Kenya Schott. With the appointment of these industry veterans, the firm continues to invest in enhancing its capabilities and services. These hires signify not only growth but also the company's...

Continue Reading
Congress Steps Up to Support Small Businesses Amid Crisis

Updated Category News Views 57

Congress Replenishes Disaster Relief Funds for Small Businesses In a significant move, Congress is working diligently to restore funds that have been depleted from the SBA Economic Disaster Loan Program. This effort comes in response to the severe challenges that small businesses are facing in regions recently impacted by catastrophic hurricanes. The aim is to provide...

Continue Reading
Data Breach at VisionPoint Eye Center Involving Patient Info

Updated Category News Views 283

Data Breach Overview at VisionPoint Eye Center Recently, VisionPoint Eye Center came under scrutiny due to a significant data breach that potentially compromised personal information of its patients. This incident highlights the importance of data security in healthcare institutions and underscores the vulnerability of sensitive information. What Happened? VisionPoint Eye...

Continue Reading
Exploring the Growth and Innovation in Blood Pressure Cuffs

Updated Category News Views 179

Overview of the Blood Pressure Cuffs Market The Blood Pressure Cuffs Market is experiencing substantial growth, growing from approximately $0.6 billion in 2024 to an anticipated $1.3 billion by 2032, representing a compound annual growth rate (CAGR) of 9.0% during the forecast period. This impressive expansion is mainly propelled by the increasing prevalence of chronic...

Continue Reading